APA (7th ed.) Citation

Duran-Castells, C., Llano, A., Kawana-Tachikawa, A., Prats, A., Martinez-Zalacain, I., Kobayashi-Ishihara, M., . . . Ruiz-Riol, M. (2023). Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction. Journal of virology, 97(2), e0165522. https://doi.org/10.1128/jvi.01655-22

Chicago Style (17th ed.) Citation

Duran-Castells, Clara, et al. "Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction." Journal of Virology 97, no. 2 (2023): e0165522. https://doi.org/10.1128/jvi.01655-22.

MLA (9th ed.) Citation

Duran-Castells, Clara, et al. "Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction." Journal of Virology, vol. 97, no. 2, 2023, p. e0165522, https://doi.org/10.1128/jvi.01655-22.